Both meetings included interactive case studies led by the international and regional faculties, mimicking real world clinical scenarios for attending doctors. Derek O’Leary, Regional Managing ...
Global Pleural Diseases Therapeutics Market to Reach USD 9.4 Billion by 2033, Growing at a 6.5% CAGR
Global Pleural Diseases Therapeutics MarketThe global market for pleural diseases therapeutics is projected to experience ...
The CEO of pharmaceuticals giant Roche has urged authorities to block the takeover of contract drug manufacturer Catalent by ...
“Additionally, consumers will also get to take advantage of RHEA Generics’ wide availability at 1,200 Mercury Drug outlets ...
Boehringer Ingelheim has axed development of a potential ... and will announce further details at the Alzheimer’s Association International Conference in July. After ending development in ...
Interview with Nicolas Poirier, CEO at OSE Immunotherapeutics a biotech with a compound that is a therapeutic cancer vaccine, ...
In 2023, the market is anticipated to be valued at USD 26.64 Billion, marking a significant starting point for a decade-long ...
The global Chronic Obstructive Pulmonary Disease (COPD) treatment market is projected to experience steady growth over the ...
AllianceQUANTRO Therapeutics and IMP enter into research collaboration to accelerate transcriptomic drug discovery 24.10.2024 / 09:30 CET/CESTThe issuer is solely responsible for the content of this ...
Progressive pulmonary fibrosis (PPF) is an increasingly recognised condition, defined in 2022 to address the progression of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback